KURA
Kura Oncology Stock Analysis
AI Rating
- Quality3/10
- Growth↓ 0/10
- Value↓ 0/10
KURA Growth
- Revenue Y/Y↑ 25.24%
- EPS Y/Y↓ -57.43%
- FCF Y/Y↓ -152.82%
KURA Profitability
- Gross margin ↑ 99.90%
- EPS margin↓ -412.90%
- ROIC 5Y↓ -39.28%
KURA Risk
- Debt / Equity↓ 0.1
- Debt / FCF↓ 0.0
- Interest coverage↓ -183.1
Kura Oncology stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.